PharmaSGP Aktie
WKN DE: A2P4LJ / ISIN: DE000A2P4LJ5
23.04.2025 14:30:08
|
EQS-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: PharmaSGP Holding SE
/ Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/#Finanzberichte Language: English Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/en/#FinancialReports Report Type: Annual financial report of the group Language: German Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/#Finanzberichte Language: English Date of disclosure: April 30, 2025 Address: https://ir.pharmasgp.com/en/#FinancialReports
23.04.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | PharmaSGP Holding SE |
Lochhamer Schlag 1 | |
82166 Gräfelfing | |
Germany | |
Internet: | https://pharmasgp.com |
End of News | EQS News Service |
|
2122398 23.04.2025 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PharmaSGPmehr Nachrichten
23.04.25 |
EQS-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (EQS Group) | |
23.04.25 |
EQS-AFR: PharmaSGP Holding SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG (EQS Group) | |
15.04.25 |
EQS-News: PharmaSGP with significant increase in revenues and EBITDA in 2024 (EQS Group) | |
15.04.25 |
EQS-News: PharmaSGP in 2024 mit deutlicher Steigerung bei Umsatz und EBITDA (EQS Group) | |
15.04.25 |
Erste Schätzungen: PharmaSGP stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
27.11.24 |
Ausblick: PharmaSGP legt Quartalsergebnis vor (finanzen.net) | |
25.11.24 |
EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, Kauf (EQS Group) | |
25.11.24 |
EQS-DD: PharmaSGP Holding SE: FUTRUE GmbH, buy (EQS Group) |
Analysen zu PharmaSGPmehr Analysen
Aktien in diesem Artikel
PharmaSGP | 23,80 | 1,71% |
|